{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T03:20:23Z","timestamp":1649042423630},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med"],"published-print":{"date-parts":[[1993,1]]},"DOI":"10.1007\/bf02261237","type":"journal-article","created":{"date-parts":[[2005,12,8]],"date-time":"2005-12-08T22:23:30Z","timestamp":1134080610000},"page":"1-3","source":"Crossref","is-referenced-by-count":3,"title":["Pain palliation and nuclear medicine"],"prefix":"10.1007","volume":"20","author":[{"given":"A. J. B.","family":"McEwan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02261237_CR1","first-page":"549","volume":"29","author":"GM Blake","year":"1988","unstructured":"Blake GM, Zivanovic MA, Blaquiere RM, Fine DR, McEwan AJ, Ackery DM (1988) Strontium-89 therapy: measurement of absorbed dose to skeletal metastases. J Nucl Med 29:549\u2013567","journal-title":"J Nucl Med"},{"key":"BF02261237_CR2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3181\/00379727-46-13009P","volume":"48","author":"LA Erf","year":"1941","unstructured":"Erf LA, Lawrence JH (1941) Phosphorous metabolism in neoplastic tissues. Proc Soc Exp Biol Med 48:694\u2013695","journal-title":"Proc Soc Exp Biol Med"},{"key":"BF02261237_CR3","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0022-5347(17)59002-3","volume":"118","author":"N Firusian","year":"1976","unstructured":"Firusian N, Mellin P, Schmidt CG (1976) Results of strontium-89 therapy in patients with carcinoma of the prostate and incurable pain from bone metastases: a preliminary report. J Urol 118:764\u2013768","journal-title":"J Urol"},{"key":"BF02261237_CR4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0001-2998(05)80156-4","volume":"22","author":"RA Holmes","year":"1992","unstructured":"Holmes RA (1992) [135Sm]EDTMP: a potential therapy for bone cancer pain. Semin Nucl Med 22:41\u201345","journal-title":"Semin Nucl Med"},{"key":"BF02261237_CR5","first-page":"1","volume":"1","author":"E Kaplan","year":"1960","unstructured":"Kaplan E, Fels IG, Kotiowski BR, Greco J, Walsh WS (1960) Therapy of carcinoma of the prostate metastatic to bone with 32p labelled condensed phosphate. J Nucl Med 1:1\u201313","journal-title":"J Nucl Med"},{"key":"BF02261237_CR6","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/0277-5379(91)90257-E","volume":"27","author":"VJ Lewington","year":"1991","unstructured":"Lewington VJ, McEwan AJ, Ackery DM, Bayly RJ, Keeling DH, MacLeod PM, Porter AT, Zivanovic MA (1991) A prospective, randomized double blind cross over study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone. Eur J Cancer 27:954\u2013958","journal-title":"Eur J Cancer"},{"key":"BF02261237_CR7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00006231-199204000-00017","volume":"13","author":"VJ Lewington","year":"1992","unstructured":"Lewington VJ, Boyer PJ, Dearnaly DP, Kirk D, Quilty PM, Yardley J, Zivanovic MA (1992)89Sr \u2014 an effective alernative to radiotherapy for prostatic metastases. Nucl Med Commun 13:211\u2013212","journal-title":"Nucl Med Commun"},{"key":"BF02261237_CR8","first-page":"2132","volume-title":"Cancer principles and practice","author":"Pm Mauch","year":"1985","unstructured":"Mauch Pm, Drew MA (1985) Treatment of metastable cancer to bone. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer principles and practice. Lippincott, Philadelphia, pp 2132\u20132141"},{"key":"BF02261237_CR9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1148\/radiology.166.2.3122267","volume":"166","author":"HR Maxon","year":"1988","unstructured":"Maxon HR, Deutsch EA, Thomms SR (1988) Re-186(Sr)HEDP for treatment of multiple metastatic foci in bone: human biodistribution and dosimetric studies. Radiology 166:501\u2013507","journal-title":"Radiology"},{"key":"BF02261237_CR10","first-page":"1877","volume":"32","author":"HR Maxon","year":"1991","unstructured":"Maxon HR, Schroder LE, Hertzberg VS, Thomas SR, Englaro EE, Samaratunga R, Smith H, Moulton JS, Williams CC, Ehrhardt GJ, Schneider HJ (1991) Re-186(Sn) HEDP for treatment of painful osseous metastases: result of a double blind crossover comparison with placebo. J Nucl Med 32:1877\u20131881","journal-title":"J Nucl Med"},{"key":"BF02261237_CR11","first-page":"608","volume":"19","author":"AJ McEwan","year":"1992","unstructured":"McEwan AJ, Porter AT, McGowan D, Amyotte G (1992) Adjuvant strontium-89 in prostate cancer: First report of the transCanada collaborative study. Eur J Nucl Med 19:608","journal-title":"Eur J Nucl Med"},{"key":"BF02261237_CR12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/07357908909038281","volume":"7","author":"JF Montebello","year":"1989","unstructured":"Montebello JF and Harston-Eaton M (1989) The palliation of osseous metastases with32P or89Sr compared with external beam and hemibody radiotherapy: an historical perspective. Cancer Investigation 7:139\u2013160","journal-title":"Cancer Investigation"},{"key":"BF02261237_CR13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0001-2998(05)80154-0","volume":"22","author":"RG Robinson","year":"1992","unstructured":"Robinson RG, Preston DF, Spicer JA, Baxter KG (1992) Radionuclide therapy of intractable bone pain: emphasis on strontium-89. Semin Nucl Med 22:28\u201332","journal-title":"Semin Nucl Med"},{"key":"BF02261237_CR14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0001-2998(05)80153-9","volume":"22","author":"EB Silberstein","year":"1992","unstructured":"Silberstein EB, Elgazzar AH, Kapilivsky A (1992) Phosphorus-32 radiopharmaceuticals for the treatment of painful osseous metastases. Semin Nucl Med 22:17\u201327","journal-title":"Semin Nucl Med"}],"container-title":["European Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02261237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02261237\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02261237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T15:12:13Z","timestamp":1558019533000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02261237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["BF02261237"],"URL":"https:\/\/doi.org\/10.1007\/bf02261237","relation":{},"ISSN":["0340-6997","1619-7089"],"issn-type":[{"value":"0340-6997","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]}}}